ESC: Short Nighttime Sleep Linked With Nearly Doubled Risk of Lower-Extremity Peripheral Arterial Disease

Sophia Antipolis — Sleeping less than five hours a night is associated with a 74% raised likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours. That’s the finding of a study published in the European Heart Journal – Open, a journal of the ESC.¹

“Our study suggests that sleeping for seven to eight hours a night is a good habit for lowering the risk of PAD,” said study author Dr. Shuai Yuan of the Karolinska Institute, Stockholm, Sweden.

More than 200 million people globally have peripheral artery disease (PAD),² where arteries in the legs are clogged, restricting blood flow and increasing the risk of stroke and heart attack. Dr. Yuan said: “Insufficient night-time sleep and daytime napping have previously been associated with a raised risk of coronary artery disease which, like PAD, is caused by clogged arteries. In addition, sleeping problems are among the top ranked complaints in PAD patients. There are limited data on the impact of sleep habits on PAD and vice versa, and our study aimed to fill that gap.”

The study included more than 650,000 participants and was conducted in two parts.³ First, the researchers analysed the associations of sleep duration and daytime napping with the risk of PAD. In the second part, the investigators used genetic data to perform naturally randomised controlled trials – called Mendelian randomisation – to examine causality of the associations.

Dr. Yuan said: “Observational analyses are limited by reverse causality – meaning that if an association between sleep habits and PAD is found, we cannot be certain if sleep habits caused PAD or having PAD caused the sleep habits. Mendelian randomisation is a robust method for evaluating causality and provides more certainty about the results.”

Taken together, the strongest evidence was for short sleep, where the relationship with PAD went both ways. In an observational analysis of 53,416 adults, sleeping less than five hours a night was associated with a nearly doubled risk of PAD compared with seven to eight hours (hazard ratio [HR] 1.74; 95% confidence interval [CI] 1.31–2.31). This finding was supported by further analyses in 156,582 and 452,028 individuals. In the causal studies, short sleep was associated with an increased risk of PAD and, in addition, PAD was associated with an increased likelihood of short sleep. Dr. Yuan said: “The results indicate that brief night-time sleep can raise the chance of developing PAD, and that having PAD increases the risk of getting insufficient sleep.”

Regarding long sleep, in an observational analysis of 53,416 adults, sleeping eight hours or more per night was linked with a 24% higher risk of PAD compared with seven to eight hours (HR 1.24; 95% CI 1.08–1.43). This finding was supported by analyses in two larger populations of 156,582 and 452,028 individuals. However, no causal relationships were found between long sleep and PAD. Similar results were reported for napping, where daytime nappers had a 32% higher risk of PAD compared to those who did not nap (HR 1.32; 95% CI 1.18–1.49) but no causal links were found. “More studies are needed on the relationships between lengthy night-time sleep, daytime napping and PAD,” said Dr. Yuan. “Although we found associations in the observational studies, we could not confirm causality.”

He concluded: “More research is needed on how to interrupt the bidirectional link between short sleep and PAD. Lifestyle changes that help people get more sleep, such as being physically active, may lower the risk of developing PAD. For patients with PAD, optimising pain management could enable them to have a good night’s sleep.” 

Funding: Funding for this study came from the Karolinska Institutet’s Research Foundation Grants (Grant number 2020-01842), the Swedish Research Council (Vetenskapsrådet; Grant Number 2019-00977), the Swedish Research Council for Health, Working Life and Welfare (Forte; 2018-00123) and the Swedish Heart-Lung Foundation (Hjärt-Lungfonden; Grant number 20190247). M.G.L. is supported by the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania and the NIH/NHLBI National Research Service Award postdoctoral fellowship (T32HL007843). S.M.D. is supported by IK2-CX001780.

Disclosures: All authors declare no conflict of interest.

References and notes

¹Yuan S, Levin MG, Titova OE, et al. Sleep duration, daytime napping, and risk of peripheral artery disease: Multinational cohort and Mendelian randomization studies. Eur Heart J Open. 2023. doi:10.1093/ehjopen/oead008.

https://academic.oup.com/ehjopen/article-lookup/doi/10.1093/ehjopen/oead008

²Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet.  2013;382:1329–1340.

³Description of the methods:

For the observational analyses, the researchers analysed the associations of sleep duration and daytime napping with the risk of PAD in two cohort studies and one case-control study. These analyses were initially done in 53,416 Swedish adults from the SIMPLER study and then repeated in 156,582 participants of the Million Veteran Program and 452,028 individuals from the UK Biobank.

For the causal analyses, the investigators used data from two genome-wide association studies to identify genetic variants associated with short sleep, long sleep and daytime napping.4,5 The naturally randomised controlled trials were conducted in participants of the Million Veteran Program, of whom 31,307 had PAD and 211,753 did not. For the first trial, the genetic variants linked with short sleep were randomly allocated to all participants at conception, giving each individual a night-time sleep duration. The investigators then analysed the association between short sleep and PAD. Two further trials were conducted for long sleep and daytime napping.

Finally, the randomised trials were conducted in the reverse direction to examine whether having PAD might influence sleep duration and napping tendency. Genetic variants associated with PAD were identified from a genome-wide meta-analysis of 637,468 participants from the Million Veteran Program and UK Biobank. These variants were randomly allocated to participants at conception, designating them as having PAD or not. The researchers then analysed the association of PAD with reported sleeping duration and napping.

⁴Dashti HS, Jones SE, Wood AR, et al. Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. Nat Commun. 2019;10:1100.

⁵Dashti HS, Daghlas I, Lane JM, et al. Genetic determinants of daytime napping and effects on cardiometabolic health. Nat Commun. 2021;12:900.

About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

About the European Heart Journal – Open 

European Heart Journal – Open is dedicated to the entire spectrum of cardiovascular medicine, with emphasis on novel research results with the potential to improve patient care.

Find More:

Peripheral Artery Disease (PAD) Topic Center

The Latest Clinical & Industry News: Cath Lab Digest

Podcasts: Cath Lab Conversations

Cardiovascular Ambulatory Surgery Centers (ASCs) Topic Center